United Skin Specialists, LLC’s Post

📝 A new study published in the Journal of the American Academy of Dermatology International by Wilsmann-Theis et al. found that guselkumab resulted in a 59.6% reduction in PPPASI at Week 24 in patients with moderate-to-severe palmoplantar pustulosis. More news: psoriasis-hub.com/ #psoriasis #MedNews #MedEd

Most viewed in the last 7 days from JAMA Dermatology: This international expert consensus statement provides guidance regarding the off-label use of low-dose oral minoxidil (LDOM). https://ja.ma/4gmyJSX

🌟 Stay Informed with our Delasco Blog! 🌟 Have you checked it out yet? 📚 Dive into a wealth of knowledge about dermatology, including product facts, industry news, trends, and intriguing insights. Explore informative posts about chemical peels and captivating interviews with dermatology experts. Stay ahead in the field and enhance your understanding. Visit our blog today! 💡https://lnkd.in/g8ENWNMx

If you are at at this year’s #EADV, learn how our network of expert dermatologists FIDE - Dermatology in Depth can support you by contacting steve.annels@avalerehealth.com. If you are at your deck but interested in finding out more on the evolving landscape of #HidradenitisSuppurativa (HS), download the infographic now. #LivingwithHS, #OptimizingTreatmentForHS, #HidradenitisSuppurativa

New publication 📝 Results from the phase II GAP trial published in the Journal of the American Academy of Dermatology International by Wilsmann-Theis et al. show that the primary endpoint was met with a 59.6% reduction in PPPASI at Week 24 with guselkumab in patients with moderate-to-severe palmoplantar pustulosis. Learn more: https://loom.ly/EJR3PXg #psoriasis #MedNews #MedEd

Most viewed in the last 7 days from JAMA Dermatology: This international expert consensus statement provides guidance regarding the off-label use of low-dose oral minoxidil (LDOM). https://ja.ma/3ZDDNNc

What you eat and drink has a profound effect on your skin. Learn more tips on how best to take care of your complexion from the experts at CMC Dermatology: https://bit.ly/3VUPKuq

Just saw this insightful conversation between Professor Faisal Ali and Dr Jablonski as they discuss the emotional challenges of hyperpigmentation. ➡ Hyperpigmentation is a skin condition that I often see in my clinic; it poses vast emotional challenges in patients suffering with the condition. ➡ For my patients, I tend to recommend dermocosmetics, such as Mela B3 Intense Anti-Dark Spot Serum from La Roche-Posay, that are specifically formulated to target the appearance of all pigment irregularities. 🌟 What is particularly unique about this product is the active ingredient Melasyl™ which visibly reduces persistent dark spots with long-lasting results. Mela B3 is suitable for sensitive skin which is why it is a great option for my patients with a wide array of skin types! Some excellent further research and scientific background may be found at the LDB Pro website: https://lnkd.in/e8BdQy9z.   #MedicalInfluencerAcademy #Ad #SkinAllianceForum #SkinAllianceForum2024 #Hyperpigmentation

🌟 The August issue of Dermatology Times is live! This month, we delve into the emerging potential of OX40 inhibitors for atopic dermatitis, the role of vitamins in rosacea management, and more. Download now and follow along as we share more throughout the month. ⬇️ https://lnkd.in/gD8-SyGi

🌟 As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in psoriasis this year. From studies exploring efficacy in skin of color to global approvals, explore more below. ⬇️ https://lnkd.in/g2pSKg_P